Robert Flaumenhaft
7Patents
2h-index
12Co-inventors
48Inventor score
Filing activity: Dec 18, 2003 → Jan 12, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7166612B2 | Methods for reducing platelet activation platelet aggregaton or thrombosis | Physics | 2 | Expired |
| US11872241B2 | Compositions and methods for reducing major thrombotic events in cancer patients | Human Necessities | 2 | Active |
| US9422262B2 | Compounds and methods for treating diseases mediated by protease activated receptors | Chemistry; Metallurgy | 1 | Active |
| US10064853B2 | Compounds for use in methods for treating diseases or conditions mediated by protein disulfide isomerase | Emerging Cross-Sectional Technologies | 0 | Active |
| US12235278B2 | Compositions and methods for evaluation of antiplatelet drug sensitivity | Physics | 0 | Active |
| US12290527B2 | Compositions and methods for reducing major thrombotic events in cancer patients | Human Necessities | 0 | Active |
| US12403123B2 | Method for treating sickle cell disease using quercetin-containing compositions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.